CONCLUSION
NAFLD, NASH, weight loss, NW
This randomized controlled clinical trial demonstrated that NW is not only feasible, acceptable, and safe but also highly efficacious in that this mHealth-delivered lifestyle intervention program led to significantly greater body weight loss than standard clinical care and at rates much greater than previous mHealth-based lifestyle intervention programs. Moreover, in a short time period, NW led to the establishment of self-monitoring behaviors necessary for long-term weight management success. Future large-scale studies with long-term follow-up are required to determine if mHealth-delivered lifestyle intervention programs can lead to sustained, long-term weight loss and improvement in routine clinical outcomes in patients with NAFLD and NASH.